Clinical and translational perspectives on αCD73 in Non-Small Cell Lung Cancer
Time: 9:00 am
day: Day Two
Details:
- Understanding key learnings from the preclinical stage that informed patient selection strategy
- Examining the benefits and drawbacks of focusing on CD73 in the adenosine pathway
